72
Views
18
CrossRef citations to date
0
Altmetric
Case Reports

Ipilimumab-induced Adenohypophysitis and Orbital Apex Syndrome: Importance of Early Diagnosis and Management

, &
Pages 176-181 | Received 10 Jul 2017, Accepted 13 Aug 2017, Published online: 20 Sep 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Abigail P. Jebaraj, Tyler J. Etheridge, Blair A. Winegar & Douglas P. Marx. (2024) Ipilimumab-related orbitopathy: a case report. Orbit 43:1, pages 100-104.
Read now
Caberry W Yu, Matthew Yau, Natalie Mezey, Ishraq Joarder & Jonathan A Micieli. (2020) Neuro-ophthalmic Complications of Immune Checkpoint Inhibitors: A Systematic Review. Eye and Brain 12, pages 139-167.
Read now
Akshay Badakere & Preeti Patil-Chhablani. (2019) Orbital Apex Syndrome: A Review. Eye and Brain 11, pages 63-72.
Read now

Articles from other publishers (15)

Amalie Chen & Bart K. Chwalisz. (2024) Update on Neuro-ophthalmic Manifestations of Immune Checkpoint Inhibitors. Current Neurology and Neuroscience Reports 24:5, pages 113-122.
Crossref
Terence Ang, Viraj Chaggar, Jessica Y. Tong & Dinesh Selva. (2024) Medication-associated orbital inflammation: A systematic review. Survey of Ophthalmology.
Crossref
Shaghayegh Habibi, Niket Patel, Steven C Plaxe & Constantin A Dasanu. (2023) Acquired angioedema late in the course of nivolumab treatment. Journal of Oncology Pharmacy Practice, pages 107815522311705.
Crossref
A. Martens, P. P. Schauwvlieghe, A. Madoe, I. Casteels & S. Aspeslagh. (2023) Ocular adverse events associated with immune checkpoint inhibitors, a scoping review. Journal of Ophthalmic Inflammation and Infection 13:1.
Crossref
Kimberly M. Winges & Lynn K. Gordon. (2022) Neuro-ophthalmic complications of immune checkpoint inhibitor therapy: Current status and future directions. Frontiers in Ophthalmology 2.
Crossref
Michel M. Sun, Nicolas Seleme, John J. Chen, Anastasia Zekeridou, Elia Sechi, Ryan D. Walsh, Johanna D. Beebe, Osama Sabbagh, Luis J. Mejico, Sean Gratton, Philip M. Skidd, David A. Bellows, Julie Falardeau, Clare L. Fraser, Cecilia Cappelen-Smith, Scott R. Haines, Bahareh Hassanzadeh, Meagan D. Seay, Prem S. Subramanian, Zoë Williams & Lynn K. Gordon. (2021) Neuro-Ophthalmic Complications in Patients Treated With CTLA-4 and PD-1/PD-L1 Checkpoint Blockade. Journal of Neuro-Ophthalmology 41:4, pages 519-530.
Crossref
LeAnne Young, Shanda Finnigan, Howard Streicher, Helen X Chen, James Murray, H Nida Sen & Elad Sharon. (2021) Ocular adverse events in PD-1 and PD-L1 inhibitors. Journal for ImmunoTherapy of Cancer 9:7, pages e002119.
Crossref
Michel M. Sun, Scott P. Kelly, Apoorva L. Mylavarapu, BS, Gary N. Holland, Anne L. Coleman, Fei Yu, Stephen Hsu, MS, Flora Lum & Lynn K. Gordon. (2021) Ophthalmic Immune-Related Adverse Events after Anti-CTLA-4 or PD-1 Therapy Recorded in the American Academy of Ophthalmology Intelligent Research in Sight Registry. Ophthalmology 128:6, pages 910-919.
Crossref
Blake H. Fortes, Prashant D. Tailor & Lauren A. Dalvin. (2021) Ocular Toxicity of Targeted Anticancer Agents. Drugs 81:7, pages 771-823.
Crossref
David Braun, Darios Getahun, Vicki Y. Chiu, Anne L. Coleman, Gary N. Holland, Fei Yu, Lynn K. Gordon & Michel M. Sun. (2021) Population-Based Frequency of Ophthalmic Adverse Events in Melanoma, Other Cancers, and After Immune Checkpoint Inhibitor Treatment. American Journal of Ophthalmology 224, pages 282-291.
Crossref
Frederick “Fritz” T. Fraunfelder & Frederick “Rick” W. Fraunfelder. 2021. Drug-Induced Ocular Side Effects. Drug-Induced Ocular Side Effects 299 360 .
Bernhard Nölle & Marcus Both. 2021. Entzündliche Augenerkrankungen. Entzündliche Augenerkrankungen 67 81 .
Vivian Paraskevi Douglas, Konstantinos A.A. Douglas & Dean M. Cestari. (2019) Immune checkpoint inhibitors. Current Opinion in Ophthalmology 30:6, pages 426-433.
Crossref
Ahmed Mekki, Laurent Dercle, Philip Lichtenstein, Ghaida Nasser, Aurélien Marabelle, Stéphane Champiat, Emilie Chouzenoux, Corinne Balleyguier & Samy Ammari. (2019) Machine learning defined diagnostic criteria for differentiating pituitary metastasis from autoimmune hypophysitis in patients undergoing immune checkpoint blockade therapy. European Journal of Cancer 119, pages 44-56.
Crossref
. (2018) Ipilimumab. Reactions Weekly 1708:1, pages 193-193.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.